4th Edition

Moderate to Severe Psoriasis

    420 Pages 56 B/W Illustrations
    by CRC Press

    Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.

    An Overview of Psoriasis, Alan Menter and Gerald Weinstein
    Evaluating Psoriasis in Patients, John Koo, Jonathan Kowalski, Mark Lebwohl, Chris Kozma, Alan Menter, and Charles Ellis
    Topical Agents in the Treatment of Moderate to Severe Psoriasis, Kristina Callis Duffin, and Gerald Krueger
    The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO, Monica Huynh and John Koo
    Systemic and Topical PUVA Therapy, Monica Huynh andWarwick Morison
    Therapy of Moderate-To-Severe PSO with MTX, Gerald Weinstein, Arisa Ortiz and Anne Marie Tremaine
    Systemic Retinoids, Daniel Butler, Tina Bhutani and John Koo
    Cyclosporine in the treatment of severe PSO, Charles Ellis
    Combination, Rotational, and Sequential Therapies, Jason Emer and Mark Lebwohl
    Pediatric Psoriasis, Maya Debbaneh, Kelly Cordoro
    Psoriatic Arthritis, Dafna Gladman
    Etanercept for Treatment of Psoriasis, Daniel Butler and John Koo
    Adalimumab in the Treatment of Psoriasis, Maya Debbaneh and John Koo
    Infliximab in the treatment of PSO, Emily Becker and John Koo
    New Agents: IL-17, JAK Kinase, Ethan Levin, Argentina Leon and John Koo
    Ustekinumab, Ethan Levin and Andrew Blauvelt
    Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of PSO, Rishu Gupta, John Koo, Jashin Wu, and Wilson Liao
    The Immunomodulatory/Immunosuppressive Classification System, John Koo, Shahrad Behnam, Shahdad Behnam, Dana Bae, Melanie Tuerk, Myriam Bernal, and Robert Dubois
    Goeckerman and Ingram Day Treatment Program, Rishu Gupta and John Koo

    Biography

    John Koo, Jashin Wu, Alice Gottlieb, Ethan Levin, Argnetina Leon